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ABSTRACT
Background: Results from observational studies regarding associ-
ations between fish (including shellfish) intake and cardiovascular
disease risk factors, including blood pressure (BP) and BMI, are
inconsistent.
Objective: To investigate associations of fish consumption and
associated urinary metabolites with BP and BMI in free-living
populations.
Methods: We used cross-sectional data from the International
Study of Macro-/Micronutrients and Blood Pressure (INTERMAP),
including 4680 men and women (40–59 y) from Japan, China, the
United Kingdom, and United States. Dietary intakes were assessed
by four 24-h dietary recalls and BP from 8 measurements. Urinary
metabolites (2 timed 24-h urinary samples) associated with fish
intake acquired from NMR spectroscopy were identified. Linear
models were used to estimate BP and BMI differences across
categories of intake and per 2 SD higher intake of fish and its
biomarkers.
Results: No significant associations were observed between fish
intake and BP. There was a direct association with fish intake and
BMI in the Japanese population sample (P trend = 0.03; fully
adjusted model). In Japan, trimethylamine-N-oxide (TMAO) and
taurine, respectively, demonstrated area under the receiver operating
characteristic curve (AUC) values of 0.81 and 0.78 in discriminating
high against low fish intake, whereas homarine (a metabolite found in
shellfish muscle) demonstrated an AUC of 0.80 for high/nonshellfish
intake. Direct associations were observed between urinary TMAO
and BMI for all regions except Japan (P < 0.0001) and in Western
populations between TMAO and BP (diastolic blood pressure: mean
difference 1.28; 95% CI: 0.55, 2.02 mmHg; P = 0.0006, systolic
blood pressure: mean difference 1.67; 95% CI: 0.60, 2.73 mmHg;
P = 0.002).
Conclusions: Urinary TMAO showed a stronger association with
fish intake in the Japanese compared with the Western population
sample. Urinary TMAO was directly associated with BP in the
Western but not the Japanese population sample. Associations
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between fish intake and its biomarkers and downstream associations
with BP/BMI appear to be context specific. INTERMAP is registered
at www.clinicaltrials.gov as NCT00005271. Am J Clin Nutr
2020;111:280–290.
Keywords: biomarkers, blood pressure, body mass index, fish,
homarine, hypertension, INTERMAPmetabolomics, metabonomics,
seafood, shellfish
Introduction
Fish (including shellfish), represents an important source of
protein for many populations; it is also a source of iodine,
selenium, vitamin D, and long-chain omega-3 PUFAs (n–3
PUFAs) (1). Fish contributes to established cardioprotective
dietary patterns such as the Mediterranean and Nordic diets
(2, 3) and is encouraged by American Heart Association and
other dietary guidelines (4, 5). The Lugalawa study was one of
the first to report a beneficial association between fish intake
and blood pressure (BP); reporting that the consumption of 300–
600 g of freshwater fish per day resulted in a lower prevalence
of hypertension compared with a vegetarian diet (6). However,
previous findings from prospective studies are inconclusive
regarding the benefit of fish intake in the management of BP.
Meta-analyses of prospective studies found a direct effect of
n–3 PUFAs on BP but no association with overall fish intake
(7), whereas another reported that dietary fish intake, rather
than n–3 PUFAs, had a consistent inverse association with
cerebrovascular disease – an end point of hypertension (8). It
has also been suggested that acute intake of lean fish may
promote lipid catabolism via increased mitochondrial efficiency
(9), but studies showing a benefit of fish intake on body
weight are lacking (10, 11). Possible contributors to these
inconsistencies include the variability of fish intake between and
within populations in terms of regularity, amount, and the species
consumed, thereby complicating the interpretation of results.
Recent research has suggested that there may be differences in
the associations between fish intake and cardiovascular disease
(CVD) mortality across geographic regions, specifically Asian
and Western regions (12). The lack of objective biomarkers of
fish intake applied in observational studies remains a further
limitation.
Metabolic profiling has proven a useful tool in advancing
the identification of objective biomarkers of dietary intakes
(13, 14). Identifying metabolic markers of fish intake has
potential to ensure more robust measurements of intake and to
elucidate mechanisms underpinning the relation between fish
intake and cardiovascular health outcomes. Several studies have
previously identified PUFAs, polychlorinated biphenyls, and
methyl mercury as metabolic markers of fish consumption in
serum (15, 16). Trimethylamine-N-oxide (TMAO), taurine, and
1-methylhistidine have been proposed as urinary biomarkers of
fish intake (17–20). A few studies have reported an inverse
relation between urinary taurine excretion and BP (21–23).
Controversy remains regarding the association of high plasma
TMAOwith CVD; recent studies propose a detrimental impact on
kidney function (24) but conversely, reduced type 2 diabetes risk
(25). The overall aims of this investigation are to: 1) measure the
associations of fish intake with CVD risk factors across Asian and
Western population samples, and 2) explore associations between
candidate metabolites as urinary biomarkers of fish intake in free-
living individuals and their associations with BP and BMI.
Methods
Study population
The International Study of Macro-/Micronutrients and Blood
Pressure (INTERMAP) from 1996 to 1999 surveyed 4680 men
and women aged 40 to 59 y from Japan, the People’s Republic of
China (PRC), the UK, and USA (26). Participants were selected
randomly from community or workplace population lists, arrayed
into 4 age/sex strata. Each participant attended 4 clinic visits,
2 on consecutive days and 2 further visits on consecutive days
on average 3 wk later (Supplemental Figure 1). Of the 4895
recruited into the study, participants were excluded if they failed
to attend all 4 clinic visits (n = 110) or had incomplete/missing
data or 24-h urine sample (n = 61), provided unreliable dietary
data (n= 7), or had extreme total energy intake (>5000 kcal/d for
women and>8000 kcal/d for men) from any 24-h recall (n= 37).
As there are no agreed parameters to determine extremes of
energy intake reporting, the upper limits of 5000 and 8000 kcal/d
were selected through consensus agreement between country
nutritionists. The final sample size was 4680 participants for
inclusion in the study (Supplemental Figure 2). Institutional
ethics committee approval was obtained for each site; all
participants provided written informed consent. INTERMAP is
registered at www.clinicaltrials.gov as NCT00005271.
Assessment of fish and dietary intakes
Dietary intakes were assessed via 4 24-h dietary recalls
administered by staff trained and certified according to a
standardized protocol following the triphasic method (27). In
Japan, PRC, and the UK, standardized 24-h paper records were
collected and coded using country-specific food tables. The
US recall data were entered electronically via the Nutrition
Data System, Nutrition coordinating Centre (Version 2.91,
University of Minnesota) to generate nutrient intake data. These
data were then standardized across all countries (26, 27).
Alcohol intake during the previous week was estimated from
7-d diaries. To account for individual differences in reporting
and total energy intake, energy adjusted dietary variables were
calculated using the nutrient density method (quantity per
1000 kcal) (28).
We defined fish as all “marine animals that live in the sea
and in freshwater lakes and rivers” (e.g., salmon, tuna, trout,
and tilapia) including shellfish (e.g., shrimp, crab, and oysters)
(4). Fish intake was estimated per person and included fish
that formed part of a composite dish (e.g., fish pie). Fish
intakes were then classified into the following groups (where
data permitted): shellfish, oily/fatty, lean, fried, raw, and salted
(Supplemental Table 1). Oily/fatty fish was categorized based
on the US definition of providing 588 mg or more of combined
EPA and DHA per 100 g of fish (4) where data were available.
The reliability of total fish intake for individuals was estimated
using the following formula: 1/[1 + (ratio/2)] × 100. The ratio
is intraindividual variance divided by interindividual variance,
estimated separately by country. The averages of the first 2
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and second 2 visits were used to account for higher correlation
between dietary intakes on consecutive days. The reliability
estimate gives an indication of the effect of random error (day-
to-day variability) on the associations with BP and BMI (29, 30).
Assessment of BP and BMI
BP was measured according to a standardized protocol
by trained staff at each visit following ≥5 min rest with a
random-zero sphygmomanometer (26). The mean of the 8 BP
measurements was calculated for use in the analyses. At clinical
visits, participants’ height and weight were measured twice and
BMI calculated as weight (kg)/height2 (m2).
Urine collection
Each participant provided 2 borate-preserved timed 24-h urine
collections ∼3 wk apart; aliquots of urine were frozen on site
(−20◦C) and air-freighted frozen to the Central Laboratory
(Leuven, Belgium) for biochemical analyses (26). Urinary
potassium and sodium were measured using emission flame
photometry and excretion values were calculated per participant
as the product of concentrations in urine and urinary volumes
corrected to 24 h. The mean of the 2 samples was calculated for
use in the current study.
Proton NMR spectroscopic analysis of urine
Urine samples were thawed completely before mixing 500
μL of urine with 250 μL of phosphate buffer (0.2 M) for
the stabilization of urinary pH at 7.4 (± 0.5), and 75 μL
of sodium 3-trimethylsilyl-(2,2,3,3-d)-1-propionate (TSP) in a
deuterium oxide (D2O; final concentration 0.1 mg/mL) solution
for chemical shift referencing of TSP (δ 0.0). Proton NMR (1H
NMR) spectra of the urine specimens were obtained at 300 K
using a Bruker Avance 600 spectrometer (Bruker Biospin) (31).
A standard one-dimensional pulse sequence (recycle delay - 90◦
- t1 - 90◦ - tm - 90◦ acquisition was used, with a relaxation delay
of 2 s and mixing time of 100 ms. A total of 64 free induction
decays were collected into 32 K data points using a spectral
width of 20 ppm (32). Baseline correction, phasing, referencing
to TSP were performed in MATLAB and spectra were reduced
to 7100 variables by integrating the intensity in adjacent spectral
bins using a segment width of δ 0.001, corresponding to the
regions δ = 0.5–9.5. The region δ 4.5–6.4, containing the residual
water and urea resonances were excluded from analyses (31).
The urine samples were randomized for the analysis and 8% of
samples were split at source and analyzed blindly as a quality
check; analytical reproducibility was high (>98%) and published
previously (33). The mean coefficients of variation for the paired
split samples, excluding those falling below the signal-to-noise
threshold (S/N ratio = 10), were estimated to be 6%, 11%,
and 13%, respectively, for TMAO (N pair = 598), taurine (N
pair = 520), and homarine (N pair = 225).
Identification of urinary metabolic biomarkers of fish intake
Analyses were performed over the whole 1H NMR spectrum,
utilizing the combined samples across the 4 populations to
uncover metabolites associated with fish consumption in our
study. Out of the study population of N = 4680, due to missing
samples (N = 50) and 575 samples considered spectral outliners
based on the principal component analysis 95% Hotelling T2
statistic, 4055 urine samples were used for metabolite discovery
analyses (31).
Univariate partial correlation analyses were performed sep-
arately on the 2 24-h urinary samples for each of the 7100
spectral variables against dietary fish and separately for shellfish
intake recall data (in grams), adjusting for age, sex, and study
center. Significantly correlated peak variables after Bonferroni
correction (P threshold = 7×10−6) in both the first and second
samples were annotated, where possible, with reference to in-
house databases and open source databases, such as the Human
Metabolome Database, and to the literature, two-dimensional
heteronuclear single-quantum correlation, total correlation spec-
troscopy, and by spiking chemical standards in urine samples
(Supplemental Table 2 and Supplemental Figures 3–7).
Assessment of covariates
Education, occupation, physical activity, smoking, medical
history, family history of high BP, and current medication
data were collected using interviewer-guided questionnaires.
Participants were also asked if they were currently following a
special diet (e.g., weight loss, health care professional advised
diet).
Statistical analyses
All statistical analyses were undertaken using SAS version
9.4 (SAS Institute Inc.) and R programming software packages
version 3.5. Baseline characteristics were reported by country
(mean and SD). Associations across categorical variables were
analyzed using the chi-squared (χ2) test. Associations between
total fish intake and BP were initially analyzed stratified by
country. Fish intake in the PRC, UK, and USA was highly
skewed with a high frequency of nonconsumers. Therefore,
individuals were grouped based on mean intake and classified
as: nonconsumers (no intake of fish recorded at any recall), low
consumers (below the median intake for consumers by country:
PRC: 14.6 g/1000 kcal; UK: 12.0 g/1000 kcal; USA: 11.8 g/1000
kcal), and high consumers (at or above the median intake by
country). Due to comparable median intakes for the USA and
UK, these population samples were pooled and the combined
median of 11.9 g/1000 kcal was used as the cut point to categorize
low and high total fish consumers. For the PRC, the population
sample was categorized as nonconsumers, consumers below
14.6 g/1000 kcal (low consumers), and equal to or above 14.6
g/1000 kcal (high consumers). As fish intake in Japan followed
an approximate normal distribution, participants were classified
into tertiles of fish intake (tertile 1: 0–35.11 g/1000 kcal; tertile
2: >35.11–53.60 g/1000 kcal; tertile 3: >53.60–174.07 g/1000
kcal). Characteristics across country-specific intake groups were
compared using general linear models adjusted for gender, age,
and study center. Post hoc Bonferroni correction was applied
to correct for multiple comparisons to determine significant
differences between the 3 groups (P < 0.017). We then used
multivariable linear regression to examine associations between
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TABLE 1 Baseline nutritional intake characteristics of INTERMAP study participants by seafood (fish and shellfish) consumption by country (consumers
and nonconsumers)
Japan PRC UK USA
Variable (n = 1145) (n = 839) (n = 501) (n = 2195)
Consumers of fish, n (%) 1142 (99) 217 (26) 277 (55) 1156 (53)
Total fish, g/1000 kcal 40.28 ± 22.26 5.46 ± 14.20 8.52 ± 12.42 8.98 ± 15.00
Fish (exc. shellfish), g/1000 kcal 36.81 ± 18.86 5.25 ± 13.94 7.90 ± 12.16 6.79 ± 13.17
Shellfish, g/1000 kcal 10.56 ± 11.21 0.20 ± 1.96 0.63 ± 2.35 2.19 ± 6.38
“Oily” fish, g/1000 kcal1 19.82 ± 13.73 — 2.58 ± 8.84 2.10 ± 7.83
Fried fish, g/1000 kcal 1.08 ± 3.01 0.27 ± 1.61 1.91 ± 5.90 —
Salted/preserved fish, g/100 kcal 8.04 ± 8.56 0.00 ± 0.00 0.05 ± 0.75 0.05 ± 0.57
Selenium intake, mcg/1000 kcal 80.08 ± 31.08 16.56 ± 4.26 44.13 ± 13.90 59.47 ± 25.92
Vitamin D intake mcg/1000 kcal — — — 2.30 ± 1.52
% Energy from PUFA 6.24 ± 1.45 5.88 ± 2.22 6.25 ± 1.91 7.16 ± 2.28
Cholesterol, mg/1000 kcal 191.43 ± 65.06 89.28 ± 84.74 120.47 ± 47.87 131.85 ± 57.53
% Protein from fish 24.41 ± 10.76 2.89 ± 6.93 4.03 ± 5.94 5.05 ± 7.85
% Total fat from fish 10.52 ± 7.42 0.99 ± 2.90 1.45 ± 3.21 0.79 ± 2.09
% PUFA from fish 9.38 ± 6.54 0.92 ± 3.08 0.89 ± 2.20 7.16 ± 2.28
% Selenium from fish 37.63 ± 16.66 4.36 ± 10.88 6.47 ± 9.14 7.33 ± 10.90
% Vitamin D from fish — — — 12.66 ± 20.23
% Cholesterol from fish 29.71 ± 16.61 7.10 ± 16.57 4.02 ± 6.78 5.61 ± 9.77
Values are means ± SD unless otherwise indicated; n = 4680. "—" data not available. PRC, People’s Republic of China.
1Defined as containing 588 mg DPA + EPA per 100 g of fish.
fish consumption with systolic BP (SBP), diastolic BP (DBP),
and BMI by country (PRC, Japan) and region (Western: USA
and UK combined; coefficients were pooled, weighted by inverse
of their variance), and total fish and shellfish intakes were
analyzed with respect to differences corresponding to 2 SD of
intake.
To test for associations between urinary metabolites identified
as putative biomarkers of fish intake, the data were split into 2
groups by study visit (Supplementary Figure 1) to align with each
24-h timed urine collection (i.e., the first urine collection, aligned
to mean dietary intakes from clinic visits 1 and 2 and the second
urine collection, aligned to mean dietary intakes from visits 3
and 4). Using this methodological approach we have previously
shown reproducible patterns of metabolite excretion (34).
Partial Pearson correlation coefficients were calculated (ad-
justed for age, sex, and study center) by country. Receiver
operating characteristic (ROC curves) analyses were performed
using the “pROC” package in R (35). Associations between
metabolites and SBP, DBP, and BMI were tested by linear
regression analyses using the mean metabolite concentration
from the 2 visits. Logarithmic transformations were applied
to urinary metabolites to approximate for normality across
analyses.
Three sequential models were constructed to test associations
between fish intake and metabolites with BP and BMI: Model 1
adjusted for: age (years, continuous), sex, study center, education
(years), physical activity (h/d), alcohol (g/d), smoking (yes/no),
vitamin supplement usage (yes/no), antihypertensive medication
(yes/no), family history of hypertension (yes/no), diagnosed
CVD (yes/no); Model 2: as Model 1 with additional adjustment
for the following continuous dietary variables: energy intake
(kcal), calcium (mg/1000 kcal), magnesium (mg/1000 kcal),
SFAs (% energy intake), plant protein (% energy intake), fiber
(g/1000 kcal), sodium (urinary), and potassium (urinary). As
obesity may lie on the causal pathway between diet and BP,
BMI (continuous variable) was added to Model 2 separately
(Model 3).
Sensitivity analyses were also performed, including analyses
of fish intake of Japanese participants only to explore potential
differential associations between categories of fish (shellfish, oily,
lean, raw, and salted fish) intake with BP and BMI; stratified
analyses by sex and category of BMI (<25, >25) and by
country. Analyses were additionally adjusted for antihypertensive
medication usage by adding 15 mmHg and 10 mmHg to SBP and
DBP, respectively (36).
Results
Descriptive statistics
Across the 4 countries the prevalence of fish consumers
was highest in Japan with 99% of participants reporting fish
or shellfish consumption at 1 or more of the study visits.
The PRC had the lowest frequency of fish consumption with
26% reporting fish or shellfish consumption at any study visit
(Table 1). Concordantly, Japan had the highest intake of fish
(mean 40.3, SD 22.3 g/1000 kcal) and the PRC recorded the
lowest (mean 5.5, SD 14.2 g/1000 kcal) . For all countries,
the majority of fish consumption came from fish; Japan had
the highest shellfish intake (mean 10.6, SD 11.2 g/1000 kcal).
Fish contributed 24.4% of the protein intake in Japan, 5.1%
in the USA, 4.0% in the UK, and 2.9% in the PRC. Fish
contributed 12.7% of the vitamin D intake in the USA and
16.7% of the selenium intake in Japan. High fish consumers in
all countries had lower adjusted mean intakes of energy from
saturated fat compared with non/low consumers. (Supplemental
Table 3). In Japan and the UK, higher fish consumers were
older compared with non/low consumers (Japan mean age 50.4
compared with 48.2 y; UKmean age 50.2 compared with 48.7 y).
The prevalence of fish intake varied by geographic region in the
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PRC, USA, and Japan; in the PRC 93.6% of those in the Southern
Guangxi province sample were classified as high consumers
whereas the Shanxi province sample in the North had the highest
prevalence of nonconsumers (42.9%); in the USA, Honolulu
had the greatest proportion of high consumers (56.9%) and
Corpus Christi the highest proportion of nonconsumers (59.4%);
(Supplemental Tables 4 and 5). Reliability estimates of total
fish intake in Japan were 83%, and the UK 84%, USA 88%, and
PRC 92%.
Associations of fish intake with BP and BMI
In the combined UK and US population sample, no asso-
ciations were observed between fish intake and BP or BMI
in either stratified analyses by intake category (Table 2) or
linear regression analyses (Supplemental Table 6). For Japanese
participants, no associations were observed between fish intake
and BP, however, there was a direct association between fish
intake and BMI; the highest compared with lowest tertiles was
24.33, SE: 0.23 compared with 23.82, SE: 0.23, P = 0.03; P for
trend= 0.0249. There was no association between fish intake and
BP or BMI by category of intake among PRC participants. Linear
regression analyses showed a direct association with fish intake
and BMI in the Japanese population sample (mean difference
0.52; 95% CI: 0.21, 0.82; P = 0.001; fully adjusted model).
Associations of type of fish intake with BP and BMI
Subgroup analyses of Japanese populations showed a border-
line inverse association between oily fish intake and DBP in
Model 1 (mean difference −1.10; 95% CI: −2.22, 0.02 mmHg;
P = 0.05), this association was significant in the fully adjusted
model including BMI (mean difference −1.38; 95% CI: −2.54,
−0.24; P = 0.02). Following adjustment for dietary factors, all
categories of fish (total, oily, and lean) except for raw fish showed
a direct association with BMI (Supplemental Table 7).
Urinary metabolic biomarkers of fish intake
TMAO (P < 1×10−23), taurine (P < 1×10−15), creatine
(P < 1×10−15), homarine (P < 1×10−13), ethyl glucuronide
(P < 1×10−11), trimethyllysine (P < 1×10−9), and dimethy-
lamine (P = 1×10−6) were found to be significantly correlated
with fish consumption (Figure 1), and homarine in particular,
was found to be strongly associated with shellfish consumption
(P< 1×10−20; Supplemental Figures 3 and 4). Partial correlation
analyses performed using the concentrations of these selected
metabolites from the first urine samples against fish and shellfish
intakes (Supplemental Figure 8) showed that in Japanese
participants, TMAO, homarine, and taurine were significantly
correlated with fish intake (P < 0.0001); homarine showed a
stronger correlation with shellfish (r = 0.46) than fish (r = 0.30).
Among Chinese participants, taurine was correlated with fish
intake (r = 0.31, P < 0.0001). ROC curve analyses were also
performed (Figure 2) which show that in Japanese participants,
TMAO and taurine, respectively, demonstrated an area under
the receiver operating characteristic curve (AUC) values of
0.81 and 0.78 for discriminating high against low total fish
intake (including shellfish). In the Japanese population sample,
homarine demonstrated an AUC of 0.80 for discriminating high
shellfish intake against participants with no recorded shellfish
intake (Figure 2B). Taurine also demonstrated an AUC of 0.82
for discriminating high against low total fish intake. Validation
using the second 24-h urinary data showed similar results
(Supplemental Figures 9 and 10).
Associations of urinary metabolites of fish intake with BP
and BMI
Analyses by country (Japan, the PRC) and region (Western: the
UK and USA) found no associations between urinary homarine
and BP (Table 3); direct associations were observed between
homarine and BMI in Japanese and Western population samples
(P < 0.05), which were attenuated following adjustment for
energy intake and other dietary factors. In Western population
samples, there was a direct association between TMAO and DBP
(mean difference per 2 SD 1.28; 95% CI: 0.55, 2.02 mmHg;
P = 0.0006; fully adjusted for lifestyle and dietary intake), this
remained significant after further adjustment for BMI (mean
difference 0.92; 95% CI: 0.19, 1.64 mmHg; P = 0.01). No
significant associations were found between TMAO and BP for
Japanese or PRC samples. There was a direct association between
TMAO and BMI in all population samples; and following
adjustment for other dietary variables this association remained
significant in PRC andWestern population samples (P< 0.0001).
In Western samples, there was an inverse association between
taurine and DBP (mean difference−0.81; 95% CI:−1.48,−0.15
mmHg; P = 0.02; fully adjusted for lifestyle and dietary intake);
following adjustment for BMI this was attenuated. There was
an inverse association between taurine and BMI in the Chinese
population sample (mean difference −1.05; 95% CI: −1.60,
−0.50; P = 0.0002; fully adjusted for lifestyle and dietary
intake), but not in the other population samples.
Sensitivity analyses
No significant associations between fish intake (g/1000 kcal)
and BP were observed in analyses stratified by sex and BMI
category (not shown). Analyses adjusted for antihypertensive
medication did not indicate any change in association between
fish intake for any country (not shown).
Discussion
To our knowledge, this is the first study to report results
from rigorous and standardized dietary assessment and BP
measurement across Asian and Western population samples
investigating associations between fish intake and urinary fish
metabolites with BP and BMI. Our null finding between fish
intake and BP supports results of a meta-analysis of controlled
trials investigating fish intake and vascular risk factors (37),
with only 1 study reporting a significant change in SBP (−4
mmHg) following a 4-wk protocol of 125 g salmon per day
(38). Although these amounts are higher than mean daily intakes
reported by INTERMAP Japanese participants (∼45 g/d for
oily/fatty fish), we did find an association between oily fish
consumption and DBP. Oily fish are high in EPA (20:5n–3)
and DHA (22:6n–3), which are precursors to prostaglandins and
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FIGURE 1 NMR spectral variables correlating to fish intake. Partial correlation analyses of total fish intake were performed. Fish intake was correlated
against each NMR intensity variable using the combined sample population from 4 countries and analyses were adjusted for age, sex, and center. Analyses were
performed on first and repeat visit samples independently. Bonferroni threshold was used for multiple testing corrections (P threshold = 7×10−6) with repeat
visit samples used as validation set. Upper panel: median spectrum of first visit samples with significantly correlated NMR variable annotated/highlighted in
red. Lower panel: Manhattan plot showing signed -log10(P) indicates the level of significance of the correlating NMR variables. Significantly correlated NMR
variables were annotated/highlighted in red. r: partial correlation coefficient. 1: 3-methyladipic acid; 2: 3-hydroxyisobutyrate; 3: ethyl glucuronide; 4: N-acetyl
neuraminate; 5: pyroglutamate; 6: dimethylamine; 7: creatine; 8: trimethyllysine; 9: trimethylamine N-oxide; 10: taurine; 11: theophylline; 12: homarine.
are thought to exert beneficial effects on BP via vasodilatory
activity (39). One potential explanation for the null finding in
the Japanese population sample for oily fish with SBP is the
combined high oily fish intake with high dietary cholesterol. We
have previously reported from INTERMAP a low-order direct
association between dietary cholesterol and BP (40). A study
in hamsters showed that dietary cholesterol intake modified n–3
PUFA metabolism and subsequently increased circulating LDL
cholesterol concentrations (41). The interaction between dietary
cholesterol and n–3 PUFA intake warrants further investigation
in humans and in relation to BP.
Our observed direct association between energy-adjusted fish
intake and BMI in the Japanese population sample is contrary to
previous findings from a large-scale European longitudinal study
reporting no difference in body weight or waist circumference
in relation to fish consumption (10, 11). Differences in ethnicity
and measurement methods may account for differences in
observations; also, in the current study we were unable to test
the association between fish intake and distribution of body fat
(e.g., waist circumference). In European populations, high fish
intake is associated with a healthy dietary pattern (6). In contrast,
a study based on data from the national dietary survey in Japan
observed no association between fish intake and adherence to
Japanese healthy eating guidelines (42), possibly reflecting that
the guidelines for animal product intake do not differentiate
between fish, shellfish, egg, and meat intake. Public health
nutrition guidance for the PRC, UK, and USA include eating
fish as part of a healthy diet: PRC: aquatic product 40–75 g/d
(43), UK: at least 2 portions per week, one of which should be
oily (portion: 140 g/4.9 oz) (44), USA: 2 servings of fish per
week (serving: 4 oz) (4). We found fish intake to be an important
contributor to selenium, n–3 PUFAs, and vitamin D (where
vitamin D data were available) intake. Thus, despite the lack
of association between fish intake and BP in our current study,
fish and shellfish consumption have other potential nutritional
health benefits. Our findings regarding fish intake are in contrast
with the direct associations we previously reported between meat
intake and BP in INTERMAP (45) and thus, highlight potential
differences in nutrient profile and health outcomes between
sources of animal protein. This difference may be due to fatty
acid profiles, with high saturated fat in red meat compared with
n–3 PUFAs in fish or to unidentified bioactive compounds within
the food matrix.
We identified 3 predominant metabolites associated with fish
intake – TMAO, homarine, and taurine. To our knowledge this
is the first time homarine, a metabolite found in the muscle of
shellfish (crustacean and mollusks) (46, 47), has been identified
as a candidate urinary marker for shellfish intake in humans.
Although we observed homarine to have a strong correlation
and specificity with shellfish compared with nonshellfish, it was
not possible in the current study to establish if homarine can
differentiate shellfish consumers from nonshellfish consumers in
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FIGURE 2 Receiver operating characteristic (ROC) curves were used to assess the predictive ability of urinary metabolites of interest in discriminating total
fish intake (including shellfish) and separately for shellfish only. A) Panels illustrate by country the ability of urinary metabolites of interest in discriminating
high fish intake from nonfish consumers (China, USA, UK) and low fish intake from nonfish consumers (Japan) using samples from the first visit. N = 753
(Japan), N = 757 (China), N = 1777 (USA), N = 409 (UK). Japan: consumers of high fish intake N = 380, consumers of low fish intake N = 373; China:
consumers of high fish intake N = 73, nonconsumers N = 684; USA: consumers of high fish intake N = 384, nonconsumers N = 1393; UK: consumers of
high fish intake N = 72, nonconsumers N = 337. B) Panel illustrates the ability of urinary metabolites of interest in discriminating high shellfish intake from
nonconsumers of shellfish (Japan only). Analysis was independently performed for first and repeat visit urine samples. TMAO, trimethylamine-N-oxide.
the Japanese population sample as the majority of participants
consumed both shellfish and nonshellfish.
Fish, along with meat, are sources of taurine, which is an
amino sulfonic acid (48). A recent meta-analysis of human
supplement trials indicated taurine supplementation (0.5–6 g/d)
reduced both DBP and SBP by ∼3 mmHg (49). However, these
trials used isolated taurine rather than increasing intake via food
and supplementation was ≤150 times higher than estimated
background intake in adults of 40–400 mg/d (48). We observed
taurine to have an inverse association with BMI, concordant with
the limited human studies that have reported weight loss with
long-term taurine supplementation, and suggested a potential
mechanistic pathway via the inhibition of white adipocyte
differentiation (50).
TMAO is found in variable concentrations in fish (51) and in
agreement with previous work (18, 19, 51), we identified TMAO
as a urinary biomarker of fish intake. However, TMAOcan also be
an indirect urinary biomarker of red meat and egg consumption.
Trimethylamine (TMA) is synthesized via gut bacteria from
dietary choline and carnitine (52) (found in eggs and red meat)
and oxidized to TMAO in the liver prior to renal excretion.
Moreover, gut microbiota profiles characterized by an enriched
ratio of Firmicutes to Bacteroidetes and low diversity have been
associated with higher TMA production in humans (53); such
a gut microbiota profile is associated with obesity (54) and
consuming a diet of poorer nutritional quality (55). Previously,
in the INTERMAP UK and US participants, we reported a direct
association between urinary TMA and BMI (56). In the present
study we observed that the association between TMAO and
BMI was independent of energy intake and key nutrients in all
population samples except the Japanese sample.We also reported
an association between urinary TMAO and DBP independent of
BMI in the INTERMAP Western population samples. A nested
case-control study in a Chinese cohort found that urinary TMAO
concentrationswere directly associatedwith central adiposity, but
in contrast to our findings, reported an inverse association with
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TABLE 3 Estimated differences in blood pressure with 2 SD higher urinary excretion of trimethylamine N-oxide, homarine, and taurine in Western, Asian,
and combined INTERMAP participants
Systolic blood pressure (mmHg) Diastolic blood pressure (mmHg) BMI
Difference (95% CI) P Difference (95% CI) P Difference (95% CI) P
TMAO (N = 4609∗, 2SD = 1.66)
Japan
Model 1 − 0.14 (−1.61, 1.33) 0.85 − 0.20 (−1.30, 0.91) 0.73 0.61 (0.28, 0.95) 0.0004
Model 2 − 0.08 (−1.69, 1.53) 0.92 − 0.19 (−1.40, 1.02) 0.76 0.31 (−0.04, 0.66) 0.08
PRC
Model 1 − 0.23 (−2.53, 2.07) 0.84 0.26 (−1.13, 1.65) 0.71 1.35 (0.89, 1.80) <0.0001
Model 2 0.21 (−2.19, 2.61) 0.86 0.26 (−1.20, 1.72) 0.73 1.16 (0.69, 1.63) <0.0001
Western (UK and USA)
Model 1 1.82 (0.80, 2.84) 0.0005 1.29 (0.59, 1.99) 0.0003 1.79 (1.38, 2.20) <0.0001
Model 2 1.67 (0.60, 2.73) 0.002 1.28 (0.55, 2.02) 0.0006 1.10 (0.68, 1.51) <0.0001
Homarine (N = 3677∗, 2SD = 2.46)
Japan
Model 1 − 0.06 (−1.64, 1.53) 0.94 − 0.76 (−1.95, 0.44) 0.21 0.46 (0.10, 0.82) 0.01
Model 2 0.21 (−1.46, 1.88) 0.80 − 0.66 (−1.91, 0.60) 0.31 0.30 (−0.06, 0.66) 0.10
PRC
Model 1 0.38 (−2.21, 2.97) 0.77 0.15 (−1.39, 1.69) 0.85 − 0.03 (−0.55, 0.49) 0.91
Model 2 0.52 (−2.08, 3.12) 0.70 0.12 (−1.43, 1.67) 0.88 − 0.18 (−0.70, 0.33) 0.49
Western (UK and US)
Model 1 0.43 (−0.71, 1.56) 0.46 − 0.02 (−0.80, 0.76) 0.95 0.55 (0.09, 1.02) 0.02
Model 2 0.46 (−0.69, 1.61) 0.43 0.00 (−0.79, 0.79) 0.99 0.27 (−0.18, 0.72) 0.24
Taurine (N = 4347∗, 2SD = 1.86)
Japan
Model 1 − 1.70 (−4.04, 0.63) 0.15 − 1.52 (−3.28, 0.23) 0.09 0.45 (−0.09, 0.98) 0.10
Model 2 − 2.10 (−4.58, 0.39) 0.10 − 1.89 (−3.75, −0.03) 0.05 − 0.10 (−0.65, 0.44) 0.71
PRC
Model 1 − 0.38 (−3.11, 2.36) 0.79 0.25 (−1.39, 1.89) 0.76 − 0.62 (−1.16, −0.09) 0.02
Model 2 − 0.56 (−3.37, 2.25) 0.70 0.03 (−1.67, 1.73) 0.97 − 1.05 (−1.60, −0.50) 0.0002
Western
Model 1 − 0.34 (−1.29, 0.62) 0.49 − 0.53 (−1.19, 0.13) 0.11 0.20 (−0.19, 0.59) 0.31
Model 2 − 0.76 (−1.73, 0.20) 0.12 − 0.81 (−1.48, −0.15) 0.02 − 0.29 (−0.67, 0.08) 0.12
Metabolites log transformed. Pooled data weighted by center. ∗Samples available for analysis <4680 due to missing samples.
Model 1 adjusted for age, sex, education (years), physical activity (hours per day), alcohol (average g/d), smoking, vitamin supplement usage (yes/no),
antihypertensive medication (yes/no), family history of hypertension (yes/no), diagnosed cardiovascular disease (yes/no).
Model 2 additional adjustment for the following continuous dietary variables: energy intake (kcal), calcium (mg/1000 kcal), magnesium (mg/1000 kcal),
%EI SFA, %EI vegetable protein, fiber (g/1000 kcal), sodium (urinary, mmol/24 h), and potassium (urinary, mmol/24 h).
TMAO: trimethylamine N-oxide.
hypertension (57). The authors also reported stronger associa-
tions with deep-fried meat and fish consumption compared with
meat and fish prepared by other cooking methods and deep-fried
plant-based foods (57). The wider profile of a population’s diet
should be considered when interpreting the clinical relevance of
urinary TMAO to cardiometabolic health outcomes. We found
no evidence that urinary TMAO is associated with BP or BMI
in a population sample with a relatively high level of fish intake
where TMAO is strongly associated with fish intake. However,
TMAO in theWestern population samples with relatively low fish
intake (where TAMO is a low predictivemarker of fish intake), we
observed direct associations between TMAO with BP and BMI
– potentially reflecting the intake of other dietary components.
Due to the complexity of associating urinary TMAO directly
to the consumption of specific food groups, further research
is needed to elucidate these differential associations observed
between populations. The 4 population samples included in this
study showed large differences in fish intake. Therefore, this
is likely to contribute to the variation in the correlations and
predictive values we observed between metabolites and intake,
with the strongest reported in the Japanese population sample
which is likely to reflect their high fish intake.
The main strengths of our study are 1) the detailed dietary
assessment aligned to 2 timed 24-h urine collections facilitating
the identification of potential novel urinary biomarkers of fish
intake and 2) the standardized methods of measurement and
data collection applied across population samples drawn from
4 countries allowing, for the first time, standardized investigation
of fish intake, BP and BMI across Asian and Western population
samples. There are also several limitations. First, fish is a food
group with sporadic patterns of intake in the PRC, UK, and USA;
therefore, 4 24-h recalls may not reflect true intake; however,
the days of recall were selected at random with ≥1 rest day to
represent different days of the week and reliability estimates were
high. Consumption in Japan was much higher than in the other
3 countries, which limited the ability to combine data across
countries. We observed significant differences in patterns of
intake across geographic regions in the PRC, therefore the limits
of generalizability should also be acknowledged in applying our
findings outside of these regions. As part of this study we did
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not determine intake of meat and eggs, which may affect TMAO
excretion: this may also have contributed to the differences in
the results observed between Asian and Western samples and
warrants further investigation. TMAO varies between species
depending on depth and salinity of fish habitat (58), a potential
determinant of urinary TMAO, however, this level of detail was
not available. Since the data collected are cross-sectional, our
observed association between fish intake and BMI in Asian
samples requires further longitudinal assessment. Our analyses
adjusted for intake of energy and other nutrients related to diet
quality (fiber, saturated fat, vegetables, and selected minerals)
but residual confounding from sample-specific dietary variables
cannot be ruled out. The method of processing and cooking fish
can impact upon the nutritional profile of the fish consumed. The
Coronary Artery Risk Development in Young Adults (CARDIA)
study at 20 y of follow-up observed inverse associations of
nonfried fish consumption on the incidence of hypertension and
BP (59). Although, we controlled our analyses for fat intake, due
to insufficient data and/or low intake of fried fish products, we
were unable to test if fried fish, independent of fat intake, was
associated with BP.
In conclusion, the INTERMAP results overall showed no
significant association between fish intake and BP in population
samples with a low and high intake of fish. However, we did
observe population sample-specific observations. Urinary TMAO
was directly associated with BMI independent of other dietary
factors in population samples with lower fish intake, and with BP
in Western but not Asian population samples. These differences
in association with health outcomes between countries require
further investigation. Future work should consider how specific
foods are consumed as part of geographic region-specific dietary
patterns and gut microbiota characterization. Additionally, explo-
ration of the potential interaction between n–3 PUFAs and dietary
cholesterol on vascular function would advance understanding of
the potential mechanisms of nutrient–nutrient interactions.
We also identified homarine as a novel urinary biomarker
of shellfish intake, which requires further validation in other
observational studies and controlled feeding studies. If our
observation can be replicated and validated in future studies, this
finding will contribute to the incremental advancement towards
the discovery of objective dietary biomarkers.
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